Cannabis Business Financial Report: Page 2

TerrAscend Reports $307 Million in 2024 Revenue

The cannabis company closed the books on its sixth consecutive quarter of positive free cash flow.

MariMed Reports Fourth Quarter and Full Year 2024 Earnings

The cannabis company reported record revenues and improved adjusted EBITDA.

TerrAscend Announces Preliminary Q4 2024 Financial Results

The company reported a net revenue of $74.4 million ahead of its scheduled earnings conference call.

Village Farms International Reports Q2/24 Results

MariMed Reports Second Quarter 2024 Earnings

The Massachusetts-based multistate operator announces financial and company highlights for Q2, including closing the acquisition of an adult-use dispensary in Upper Marlboro, Md., and of Thrive Dispensary in Casey, Ill., and receiving a provisional dual-license for its Tiffin, Ohio, dispensary.

Curaleaf Reports $342 Million in Q2 Revenue

The global cannabis company now operates in 15 countries.

The Cannabist Co. Reports Second Quarter 2024 Financial Results

The company reported $125 million in revenue for the period.

Cresco Labs Determines IRS Section 280E Not Applicable to its Business

The company reported an improvement of more than 800 basis points year-over-year in its adjusted EBITDA margin for the second quarter of 2024.

Jushi Holdings Inc. Reports Second Quarter 2024 Financial Results

The Florida-based multistate operator shares Q2 financial and company highlights, including its appointment of former Cresco executive Todd West as COO, its debut of 308 new unique SKUs across the company’s five vertical markets, a net loss of $1.9 million, compared to $14.0 million in Q2 2023, and the refinancing of the company's first lien debt with SunStream Bancorp Inc.

Verano Reports $222 Million in Revenue for Q2

The company’s second quarter 2024 financial performance featured the authorization of a share repurchase program.

Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow

The Canadian company notes positive free cash flow of $6.5 million, record net revenue of $47.2 million in global medical cannabis and an end to the fiscal quarter debt-free with a cash position of approximately $182 million.

AYR Wellness Reports Second Quarter 2024 Results

The company addresses 'near-term setbacks,' while highlighting how it is positioned both 'for growth and margin expansion in the second half of 2024,' following adult-use rollout in Ohio, and to capitalize on anticipated adult-use markets in Florida, and Pennsylvania.

Previous Page

Page 2 of 7

Next Page